Table 3:
Open in new tab

Definition of perioperative myocardial infarction after cardiac valve surgery

DefinitionYearTime after procedurePeak biomarker thresholdSupporting evidence
VARC 3 [72]2013Within 48 hCK-MB ≥10× URL (or troponin ≥70× URL)None
CK-MB ≥5× URL (or Troponin ≥35× URL)

  • One or more of the following:

  • ECG: New Q-waves or new persistent LBBB

  • Angiographic: Flow-limiting angiographic complications in a major epicardial vessel or >1.5 mm diameter branch

  • Imaging: Substantial new loss of viable myocardium on imaging related to the procedure

MVARC [73]2012Within 48 hCK-MB >10× URLECG: New ST-segment elevation or depression of ≥1 mm in ≥2 contiguous leads (measured 80 ms after the J-point)
CK-MB >15× URLECG: New Q-waves or new persistent LBBB
DefinitionYearTime after procedurePeak biomarker thresholdSupporting evidence
VARC 3 [72]2013Within 48 hCK-MB ≥10× URL (or troponin ≥70× URL)None
CK-MB ≥5× URL (or Troponin ≥35× URL)

  • One or more of the following:

  • ECG: New Q-waves or new persistent LBBB

  • Angiographic: Flow-limiting angiographic complications in a major epicardial vessel or >1.5 mm diameter branch

  • Imaging: Substantial new loss of viable myocardium on imaging related to the procedure

MVARC [73]2012Within 48 hCK-MB >10× URLECG: New ST-segment elevation or depression of ≥1 mm in ≥2 contiguous leads (measured 80 ms after the J-point)
CK-MB >15× URLECG: New Q-waves or new persistent LBBB

CK-MB: creatine kinase MB; ECG: electrocardiogram; LBBB: left bundle branch block; MVARC: Mitral Valve Academic Research Consortium; URL: upper reference limit; VARC-3: Valve Academic Research Consortium-3.

Table 3:
Open in new tab

Definition of perioperative myocardial infarction after cardiac valve surgery

DefinitionYearTime after procedurePeak biomarker thresholdSupporting evidence
VARC 3 [72]2013Within 48 hCK-MB ≥10× URL (or troponin ≥70× URL)None
CK-MB ≥5× URL (or Troponin ≥35× URL)

  • One or more of the following:

  • ECG: New Q-waves or new persistent LBBB

  • Angiographic: Flow-limiting angiographic complications in a major epicardial vessel or >1.5 mm diameter branch

  • Imaging: Substantial new loss of viable myocardium on imaging related to the procedure

MVARC [73]2012Within 48 hCK-MB >10× URLECG: New ST-segment elevation or depression of ≥1 mm in ≥2 contiguous leads (measured 80 ms after the J-point)
CK-MB >15× URLECG: New Q-waves or new persistent LBBB
DefinitionYearTime after procedurePeak biomarker thresholdSupporting evidence
VARC 3 [72]2013Within 48 hCK-MB ≥10× URL (or troponin ≥70× URL)None
CK-MB ≥5× URL (or Troponin ≥35× URL)

  • One or more of the following:

  • ECG: New Q-waves or new persistent LBBB

  • Angiographic: Flow-limiting angiographic complications in a major epicardial vessel or >1.5 mm diameter branch

  • Imaging: Substantial new loss of viable myocardium on imaging related to the procedure

MVARC [73]2012Within 48 hCK-MB >10× URLECG: New ST-segment elevation or depression of ≥1 mm in ≥2 contiguous leads (measured 80 ms after the J-point)
CK-MB >15× URLECG: New Q-waves or new persistent LBBB

CK-MB: creatine kinase MB; ECG: electrocardiogram; LBBB: left bundle branch block; MVARC: Mitral Valve Academic Research Consortium; URL: upper reference limit; VARC-3: Valve Academic Research Consortium-3.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close